Healthcare News and Research

Latest Healthcare News and Research

Less invasive endovascular aortic repair benefits most patients, provides quick recovery

Each year, nearly 40,000 Americans undergo elective surgery to repair an abdominal aortic aneurysm with the goal of preventing a life-threatening rupture of this potentially dangerous cardiovascular condition.

24 Jul 2015

Mana Health's software ManaPortal obtains ONC HIT 2014 Edition Modular EHR certification

Mana Health's ManaPortal version 1.0.0, has achieved ONC HIT 2014 Edition Modular EHR certification, which designates that the software is capable of supporting eligible providers and hospitals with meeting the Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act.

23 Jul 2015

Amgen announces submission of supplemental New Drug Application to FDA for Kyprolis (carfilzomib)

Amgen today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration for Kyprolis (carfilzomib) for Injection to seek an expanded indication for the treatment of patients with a form of blood cancer, relapsed multiple myeloma, who have received at least one prior therapy.

23 Jul 2015

Ten Genesis HealthCare facilities named recipients of Silver – Commitment to Quality Award

Genesis HealthCare, one of the nation's largest providers of post-acute care, today announced that 10 of its Centers have been recognized as 2015 recipients of the Silver – Commitment to Quality Award for dedication to improving the lives of patients and residents through quality care.

23 Jul 2015

ADPT generates systemwide net patient services revenue of $104.5 million for Q2 2015

Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., announced its results for the second quarter ended June 30, 2015.

23 Jul 2015

Quest Diagnostics' second quarter revenue grows by 1.2% to $1.93 billion

Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that for the second quarter ended June 30, 2015, adjusted net income was $170 million compared to $157 million for 2014. Adjusted diluted EPS excluding amortization was $1.25 in the second quarter of 2015, compared to $1.19 in 2014. Amortization expense per diluted share was $0.08 in the second quarter of 2015 and $0.11 in 2014.

From Quest Diagnostics 23 Jul 2015

Experts to highlight new diagnostic products, tools to identify heart attacks at 2015 AACC Annual Meeting

The 2015 AACC Annual Meeting & Clinical Lab Expo, the leading annual event for laboratory medicine, will open on Sunday, July 26, in Atlanta, Georgia. This year's meeting will host more than 400 educational sessions on topics ranging from personalized medicine and infectious diseases to point-of-care and laboratory-developed tests, and will feature more than 200 new cutting edge diagnostic products.

23 Jul 2015

Availability of primary care appointments improves for people with Medicaid in Michigan

Getting access to health insurance, and getting access to a doctor, are two very different things. But a new University of Michigan study suggests that the two have gone hand-in-hand in the state of Michigan, despite a rapid influx of hundreds of thousands of newly insured people under the state's expansion of Medicaid.

23 Jul 2015

Researchers examine brain networks involved in PTSD and TBI

Posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) can have devastating consequences. Both are associated with high rates of disability and suicide, and although they are separate conditions, they commonly co-occur. For example, a soldier who has developed PTSD as a result of a traumatic experience may have also sustained a brain injury during that experience.

23 Jul 2015

Danaher's revenue for second quarter 2015 increases 3.5% to $5.1 billion

Danaher Corporation today announced record results for the second quarter 2015. For the quarter ended July 3, 2015, non-GAAP adjusted diluted net earnings per share were $1.08, which reflects the adjustments identified in the attached reconciliation schedule. On a GAAP basis, diluted net earnings for the second quarter were $696 million, or $0.97 per share. Revenue for the second quarter 2015 increased 3.5% to $5.1 billion with core revenues also increasing 3.5%.

23 Jul 2015

Adherium partners with AstraZeneca to improve health outcomes for people with respiratory conditions

New Zealand-based Adherium (NZ) Limited has entered a long term partnership with international pharmaceutical leader AstraZeneca in what the company believes is a world-first commercial arrangement combining digital health technology with blockbuster inhaler medications to improve health outcomes for patients with respiratory conditions.

23 Jul 2015

Veeva OpenData services now available in Italy

Today, Veeva Systems announced that it has acquired Merqurio's healthcare professional (HCP) and healthcare organisation (HCO) database for Italy. With the acquisition of this market-leading Italian HCP and stakeholder data, Veeva OpenData now expands to a third major European market and builds on Veeva's commitment to deliver a new approach to customer reference data that is open, easy, and global.

23 Jul 2015

Study looks at impact of amyloid imaging on diagnosis, management of patients with cognitive impairment

Eli Lilly and Company and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced new data showing that knowledge of amyloid status as determined by Florbetapir F 18 Injection imaging altered diagnosis and management in the majority of patients being studied.

23 Jul 2015

Retail meat harbors disease-causing Klebsiella pneumoniae, shows new study

Chicken, turkey and pork sold in grocery stores harbors disease-causing bacteria known as Klebsiella pneumoniae, according to a new study. The research, which was published online today in the journal Clinical Infectious Diseases, shows that contaminated meat may be an important source of human exposure to Klebsiella.

23 Jul 2015

Researchers develop diagnostic test to detect enterovirus D68

Researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year. The outbreak caused infections at an unprecedented rate, with over 1,000 confirmed cases and 14 reported deaths nationwide, according to the Centers for Disease Control and Prevention.

23 Jul 2015

MediCollector to commercialize Wyss Institute's bedside data-acquisition software

The Wyss Institute for Biologically Inspired Engineering at Harvard University today announced that its bedside data-acquisition software will be commercialized by a recently formed startup company, MediCollector LLC. The announcement follows a worldwide license agreement between Harvard's Office of Technology Development and MediCollector.

23 Jul 2015

More people turn to popular new blood thinners for atrial fibrillation treatment

More adults than ever are visiting their doctors' offices for a prescription to treat atrial fibrillation, according to a study led by the University of Michigan Frankel Cardiovascular Center.

23 Jul 2015

Genetic variation influences survival in patients with multiple myeloma

As part of a multi-institutional effort, researchers with Huntsman Cancer Institute at the University of Utah have found that multiple myeloma patients with a genetic variation in the gene FOPNL die on average 1-3 years sooner than patients without it.

23 Jul 2015

Perrigo signs agreement to acquire Naturwohl Pharma

Perrigo Company plc today announced that it has entered into an agreement to acquire Naturwohl Pharma GmbH with its leading German dietary supplement brand, Yokebe. The brand is expected to generate approximately €30 million in full year 2015 net sales.

22 Jul 2015

KalVista raises $33 million in Series B financing to support development of plasma kallikrein inhibitors

KalVista Pharmaceuticals, a research-led pharmaceutical company, today announced it has raised $33 million in a Series B financing to support its research and clinical development programs. KalVista will use the funds to advance its proprietary portfolio of plasma kallikrein inhibitors for treating diabetic macular edema (DME) and hereditary angioedema (HAE).

22 Jul 2015

Healthcare News and Research

Latest Healthcare News and Research

Less invasive endovascular aortic repair benefits most patients, provides quick recovery

Mana Health's software ManaPortal obtains ONC HIT 2014 Edition Modular EHR certification

Amgen announces submission of supplemental New Drug Application to FDA for Kyprolis (carfilzomib)

Ten Genesis HealthCare facilities named recipients of Silver – Commitment to Quality Award

ADPT generates systemwide net patient services revenue of $104.5 million for Q2 2015

Quest Diagnostics' second quarter revenue grows by 1.2% to $1.93 billion

Experts to highlight new diagnostic products, tools to identify heart attacks at 2015 AACC Annual Meeting

Availability of primary care appointments improves for people with Medicaid in Michigan

Researchers examine brain networks involved in PTSD and TBI

Danaher's revenue for second quarter 2015 increases 3.5% to $5.1 billion

Adherium partners with AstraZeneca to improve health outcomes for people with respiratory conditions

Veeva OpenData services now available in Italy

Study looks at impact of amyloid imaging on diagnosis, management of patients with cognitive impairment

Retail meat harbors disease-causing Klebsiella pneumoniae, shows new study

Researchers develop diagnostic test to detect enterovirus D68

MediCollector to commercialize Wyss Institute's bedside data-acquisition software

More people turn to popular new blood thinners for atrial fibrillation treatment

Genetic variation influences survival in patients with multiple myeloma

Perrigo signs agreement to acquire Naturwohl Pharma

KalVista raises $33 million in Series B financing to support development of plasma kallikrein inhibitors

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in